GEROTHERAPEUTIX
"GEROTHERAPEUTIX" is a word mark owned by Senotherapeutix, Inc., filed at the USPTO on April 9, 2026. It is under examination and covers class 3 (Cosmetics and Cleaning Preparations).
- Status
- Under examination
- Since August 19, 2026
- Filed
- April 9, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99753230
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns GEROTHERAPEUTIX
The owner and representative on file with the office.
Owner
Senotherapeutix, Inc.
Surfside, United States
Representative
Jared L. DuJack
Schmeiser, Olsen & Watts, LLP
What the mark covers
The products and services GEROTHERAPEUTIX is filed for, grouped by Nice class.
Anti-aging cream; Non-medicated anti-aging serum; Cosmetic anti-aging products, namely, anti-aging creams, serums, moisturizers, tonics, and cleansers; Cosmetic preparations; Cosmetic creams for skin care; Cosmetic preparations for skin care; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Synthesized peptides for use in treating age-related diseases and cancer; Synthesized peptides for use in skin conditions; Synthesized peptides, namely anti-aging peptides; Synthesized peptides for use in prevention of radiation damage; Synthesized peptides for use in treatment of radiation damage; Synthesized peptides for use in prevention of radiation related diseases; Synthesized peptides for use in treatment of radiation related diseases; Synthesized peptides for use in treatment of obesity; Synthesized peptides for use in weight loss regimens, Synthesized peptides for use in treatment of obesity in combination with other drugs; Synthesized peptides, namely, peptides for use in cosmetics; Synthesized peptides, namely, anti-aging peptides for use in cosmetics; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, and development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Cosmetic research; Development of cosmetic preparations; Research and development of cosmetic preparations; Gene therapy research; Gene therapy research related to anti-aging; Gene therapy research related to cancer; Gene therapy related to prevention and treatment of radiation damage and radiation related diseases; Gene therapy related to treatment of obesity; Gene therapy related to weight loss regimens; Gene therapy related to treatment of obesity in combination with other drugs; Anti-aging research; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Anti-aging therapy; Medical services, namely, anti-aging services; Medical testing services, namely, biologic age scoring; Medical testing services in the nature of statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services, namely, biopsy services; Medical testing services, namely, biopsy services related to biologic age; Medical testing services, namely, biopsy services related to biological age scoring; Medical testing services, namely, biopsy services related to determining a number or percentage of senescent cells; Laboratory services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Laboratory services related to biologic age, namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Laboratory services related to biological age scoring, namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, laboratory services related to determining a number or percentage of senescent cells; Non-invasive medical testing; Non-invasive medical testing related to biologic age; Non-invasive medical testing related to biological age scoring; Non-invasive medical testing related to determining a number or percentage of senescent cells; Medical care, namely, prevention of radiation damage; Medical care, namely, treatment of radiation damage; Medical care, namely, prevention of radiation related diseases; Medical care, namely treatment of radiation related diseases; Medical care, namely, treatment of obesity; Providing weight loss program services in the nature of weight loss regimens; Medical care, namely, treatment of obesity in combination with other drugs; Consulting services in the fields of medical care pertaining to anti-aging and cosmetics; Medical skin care services, namely, biologic age scoring for use in cosmetics; Medical care, namely, statistical scoring to determine a biologic age score of an individual
What has happened so far
Steps recorded by the USPTO, newest first.
- Notification of non-final action e-mailed
- Non-final action e-mailed
- Non-final action written
- Notification of non-final action e-mailed
- Non-final action e-mailed
- Non-final action written
- Assigned to examiner
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About GEROTHERAPEUTIX
Who owns the trademark "GEROTHERAPEUTIX"?
The USPTO trademark "GEROTHERAPEUTIX" (application 99753230) is owned by Senotherapeutix, Inc.
What is the status of "GEROTHERAPEUTIX"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull GEROTHERAPEUTIX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d7f51-4f27-7181-8251-5c28f7d453c2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d7f51-4f27-7181-8251-5c28f7d453c2",
"object": "trademark",
"mark_text": "GEROTHERAPEUTIX",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99753230",
"filing_date": "2026-04-09",
"nice_classes": [
3
],
"owners": [
{
"name": "SENOTHERAPEUTIX, Inc.",
"entity_id": null
}
]
}